What is the price target for IPA stock?
6 analysts have analysed IPA and the average price target is 5.1 USD. This implies a price increase of 146.38% is expected in the next year compared to the current price of 2.07.
IMMUNOPRECISE ANTIBODIES LTD (IPA) Forecast, Price Target & Analyst Ratings
NASDAQ:IPA • CA45257F2008
Current stock price
2.07 USD
+0.14 (+7.25%)
At close:
2.12 USD
+0.05 (+2.42%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for IMMUNOPRECISE ANTIBODIES LTD (IPA).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Dec 8, 2025
- Period
- Q1 / 2026
- EPS Estimate
- -CA$0.06
- Revenue Estimate
- 6.313M
Price Target Details & History
Consensus Price Target and Range
Mean target
$5.10
Upside
+ 146.38%
From current price of $2.07 to mean target of $5.10, Based on 6 analyst forecasts
Low
$5.05
Median
$5.10
High
$5.25
Price Target Revisions
1 Month
25.00%
3 Months
25.00%
Price Target Summary
6 Wall Street analysts provided a forecast for the next 12 months for IPA. The average price target is 5.1 USD. This implies a price increase of 146.38% is expected in the next year compared to the current price of 2.07.
The average price target has been revised upward by 25% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
IPA was analyzed by 6 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about IPA.
In the previous month the buy percentage consensus was at a similar level.
IPA was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-04-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-01 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2025-03-31 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-09-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-14 | Benchmark | Maintains | Speculative Buy -> Speculative Buy |
| 2024-07-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-15 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2024-03-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-11 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2023-03-21 | Benchmark | Maintains | Speculative Buy |
| 2023-03-17 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-12-02 | HC Wainwright & Co. | Initiate | Buy |
| 2021-10-25 | Benchmark | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Dec 8, 2025
- Period
- Q1 / 2026
- EPS Estimate
- -CA$0.06
- Revenue Estimate
- 6.313M
- Revenue Q2Q
- 19.95%
- EPS Q2Q
- 62.97%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
-2.34%
EPS (1 Month)
0.00%
EPS (3 Months)
-10.00%
Next Earnings Summary
IPA is expected to report earnings on 12/8/2025. The consensus EPS estimate for the next earnings is -0.06 USD and the consensus revenue estimate is 6.31M USD.
The next earnings revenue estimate has been revised downward by 2.34% in the past 3 months.
Full Analyst Estimates 2026 - 2032
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 20.665M 6.72% | 24.518M 18.65% | 24.52M 0.01% | 29.119M 18.76% | 38.479M 32.14% | 43.754M 13.71% | 50.593M 15.63% | 58.522M 15.67% | 67.717M 15.71% | 78.385M 15.75% | |
| EBITDA YoY % growth | -21.866M -75.29% | -8.358M 61.78% | -7.257M 13.17% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -28.551M -75.77% | -14.093M 50.64% | -12.376M 12.18% | -5.675M 54.14% | 2.82M 149.69% | 7.274M 157.94% | 13.023M 79.03% | 17.633M 35.40% | 25.978M 47.33% | 34.056M 31.10% | |
| Operating Margin | -138.16% | -57.48% | -50.47% | -19.49% | 7.33% | 16.62% | 25.74% | 30.13% | 38.36% | 43.45% | |
| EPS YoY % growth | N/A -24.37% | -0.46 56.21% | -0.30 34.78% | -0.15 49.50% | 0.06 140.00% | 0.15 150.00% | 0.67 340.00% | 0.97 46.15% | 1.24 27.31% | N/A |
All data in CAD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.06 62.97% | -0.05 49.50% | -0.05 -405.00% | -0.04 29.30% |
| Revenue Q2Q % growth | 6.313M 19.95% | 6.969M 13.78% | 7.02M 14.13% | 7.777M 11.40% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -2.222M 53.45% | -2.071M 27.12% | -2.323M 29.37% | -2.172M -47.32% |
All data in CAD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
35.81%
EPS Next 5 Year
39.31%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
19.46%
Revenue Next 5 Year
17.92%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
IMMUNOPRECISE ANTIBODIES LTD / IPA Forecast FAQ
What is the next earnings date for IPA stock?
IMMUNOPRECISE ANTIBODIES LTD (IPA) will report earnings on 2025-12-08.
Can you provide the consensus estimates for IMMUNOPRECISE ANTIBODIES LTD next earnings?
The consensus EPS estimate for the next earnings of IMMUNOPRECISE ANTIBODIES LTD (IPA) is -0.06 USD and the consensus revenue estimate is 6.31M USD.
What is the expected long term growth rate for IMMUNOPRECISE ANTIBODIES LTD (IPA)?
The expected long term growth rate for IMMUNOPRECISE ANTIBODIES LTD (IPA) is 19.46%.